BIT
NVCR icon

BlackRock Institutional Trust’s NovoCure NVCR Stock Holding History

BlackRock Institutional Trust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.76M Buy
479,383
+10,058
+2% +$80.9K ﹤0.01% 2824
2016
Q3 		$4.01M Buy
469,325
+37,453
+9% +$342K ﹤0.01% 2784
2016
Q2 		$5.04M Buy
431,872
+364,061
+537% +$4.56M ﹤0.01% 2678
2016
Q1 		$982K Buy
67,811
+14,827
+28% +$213K ﹤0.01% 3288
2015
Q4 		$1.19M Buy
+52,984
New +$1.27M ﹤0.01% 3284

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $67.3M AUM 9.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Institutional Trust's NVCR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its NovoCure (NVCR) stake by 2.1% in Q4 2016, buying an estimated $80.9K and bringing the position to 479,383 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

BlackRock Institutional Trust first reported a position in NVCR in Q4 2015 and has held it in 5 quarters since. The position peaked at $5.04M in Q2 2016. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

  • BlackRock Institutional Trust held 479,383 shares of NovoCure worth $3.76M as of Q4 2016.
  • BlackRock Institutional Trust bought 10,058 NovoCure shares in Q4 2016, an estimated $80.9K.
  • NovoCure made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2824 holding.
  • BlackRock Institutional Trust first reported a position in NovoCure in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Institutional Trust's NovoCure position peaked at $5.04M in Q2 2016.
  • 78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.